Clinical Trials Logo

Filter by:
NCT ID: NCT00190606 Completed - Clinical trials for Urinary Stress Incontinence

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence

Start date: January 2002
Phase: Phase 2
Study type: Interventional

The study is a comparison of the efficacy and safety of duloxetine and pelvic floor muscle training with that of placebo in patients with moderate to severe stress urinary incontinence

NCT ID: NCT00189839 Completed - Clinical trials for Kidney Transplantation

A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation

Start date: August 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate and to compare the efficacy and safety of a triple modified release tacrolimus FK506E (MR4) / MMF / steroid regimen with a triple standard tacrolimus FK506 / MMF / steroid regimen in patients undergoing kidney transplantation. It shall be demonstrated that FK506E (MR4) is non-inferior to FK506 with regards to the primary endpoint.

NCT ID: NCT00189735 Completed - Clinical trials for Kidney Transplantation

A Study to Evaluate FK778 in Kidney Transplant Patients

Start date: September 2003
Phase: Phase 2
Study type: Interventional

A dose finding study to evaluate the safety and effectiveness of FK778 in kidney transplant patients

NCT ID: NCT00189215 Completed - Clinical trials for Coronary Artery Disease

Long-Term Cognitive Decline After Coronary Artery Bypass Grafting: is Off-Pump Surgery Beneficial?

Start date: March 1998
Phase: Phase 4
Study type: Interventional

Coronary artery bypass surgery is associated with postoperative cognitive decline, which has largely been attributed to the use of the heart lung machine. We hypothesized that long-term cognitive outcome may improve by avoiding the heart lung machine. The objective of the present study is to compare the effect of coronary bypass surgery with and without heart lung machine on cognitive and clinical outcome, five years after surgery.

NCT ID: NCT00189111 Completed - Clinical trials for Peripheral Arterial Disease

Non-invasive Cardiac Screening in High Risk Patients -The GROUND Study

Start date: January 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to find out if subjecting cardiac high risk patients to non invasive cardiac imaging, followed by treatment will improve survival and quality of life

NCT ID: NCT00189098 Completed - Clinical trials for Chronic Otitis Media

Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media

Start date: February 2003
Phase: N/A
Study type: Interventional

Chronic suppurative otitis media is one of the most common chronic infections in children worldwide. Symptoms include otorrhea, otalgia and hearing loss. In many countries, it is treated primarily with antibiotics; in other countries such as the Netherlands a surgical approach, such as a tonsillectomy, adenoidectomy, placement or removal of tympanostomy tubes or a tympanomastoidectomy is preferred. There is however, no agreement on the management of this disease. The purpose of this study is to determine the effectiveness of treatment with sulfamethoxazole-trimethoprim for 6-12 weeks in children suffering from chronic otitis media and otorrhea.

NCT ID: NCT00189085 Completed - Metabolic Syndrome Clinical Trials

Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function

Start date: December 2004
Phase: Phase 4
Study type: Interventional

In the present study the investigators are researching the effects of the cholesterol absorption inhibitor ezetimibe on postprandial lipemia and postprandial endothelial function in patients with the metabolic syndrome. The lipid-lowering effect of high-dose statin monotherapy on fasting lipids is equal to the combination therapy of low-dose statin and ezetimibe.

NCT ID: NCT00189033 Completed - Clinical trials for Colonic Diseases, Functional

Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre?

Start date: April 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the role of dietary fibre in Irritable Bowel Syndrome (IBS) treatment, in particular the role of increasing the content of soluble or insoluble fibres in the daily diet. The primary objective is to compare soluble (psyllium) and insoluble (bran) to placebo, administered over 12 weeks in patients with ‘probable’ or ‘definite’ Irritable Bowel Syndrome. The primary efficacy parameter is the responder rate based on weekly assessment of adequate relief of IBS symptoms. Secondary efficacy parameters include changes in IBS related symptoms (abdominal pain, bowel habits) and quality of life.

NCT ID: NCT00185458 Completed - Menopause Clinical Trials

Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).

Start date: May 2000
Phase: Phase 3
Study type: Interventional

The study has been designed to look at the transfer from using LNG IUS for contraception only, in reproductive age to using it for endometrial protection in menopausal age. The main area of interest in the study is the pattern of any vaginal bleeding that occurs.

NCT ID: NCT00185393 Completed - Clinical trials for Lymphoma, Non-Hodgkin

Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy

Start date: August 2001
Phase: Phase 3
Study type: Interventional

The aim of the study is to test [90]Y-ibritumomab tiuxetan, a radioactive antibody, in patients with stage III or IV follicular lymphoma whose disease is in partial or complete remission after first line chemotherapy. The radioactive antibody will be compared with no further treatment to see which is better in the long term after standard lymphoma treatment.